| Product Code: ETC6209799 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Austria Pharmacogenetic Testing Market Overview |
3.1 Austria Country Macro Economic Indicators |
3.2 Austria Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Austria Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Austria Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Austria Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Austria Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 Austria Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Austria Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 Austria Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Austria Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Austria Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Austria Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and targeted therapies |
4.2.2 Growing awareness about the benefits of pharmacogenetic testing in optimizing drug therapies |
4.2.3 Technological advancements in genetic testing leading to more accurate and cost-effective tests |
4.3 Market Restraints |
4.3.1 Limited reimbursement policies for pharmacogenetic testing |
4.3.2 Lack of standardized guidelines for the implementation of pharmacogenetic testing |
4.3.3 Concerns regarding data privacy and ethical issues related to genetic testing |
5 Austria Pharmacogenetic Testing Market Trends |
6 Austria Pharmacogenetic Testing Market, By Types |
6.1 Austria Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Austria Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Austria Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Austria Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Austria Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 Austria Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 Austria Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 Austria Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 Austria Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 Austria Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 Austria Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 Austria Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 Austria Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 Austria Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Austria Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 Austria Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 Austria Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 Austria Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 Austria Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 Austria Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 Austria Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 Austria Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 Austria Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 Austria Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Austria Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Austria Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 Austria Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 Austria Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 Austria Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 Austria Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 Austria Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Austria Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Austria Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Austria Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 Austria Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 Austria Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 Austria Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Austria Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 Austria Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 Austria Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Austria Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Austria Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 Austria Pharmacogenetic Testing Market Export to Major Countries |
7.2 Austria Pharmacogenetic Testing Market Imports from Major Countries |
8 Austria Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Adoption rate of pharmacogenetic testing by healthcare providers |
8.2 Number of research studies highlighting the efficacy of pharmacogenetic testing |
8.3 Rate of integration of pharmacogenetic testing into clinical practice |
9 Austria Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 Austria Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Austria Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 Austria Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Austria Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 Austria Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Austria Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Austria Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Austria Pharmacogenetic Testing Market - Competitive Landscape |
10.1 Austria Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Austria Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here